Implementation of quantitative integral analysis in assessing events associated with safety issues during clinical trials: focusing on trastuzumab
https://doi.org/10.37489/2588-0519-2024-4-21-34
EDN: ZEWDXG
Abstract
The authors developed a methodology for an in-depth study of the safety of pharmacotherapy based on a quantitative integrated analysis of adverse events in the context of clinical trials. The methodology was tested using data obtained during a bioequivalence study of trastuzumab.
Objective. Practical implementation of the approaches developed by the authors for the individualized assessment of safety of pharmacotherapy based on quantitative integral analysis of adverse events.
Materials and methods. This five-step algorithm modifies information regarding registered adverse events during clinical trials. Subsequent integral assessment of adverse drug events, in which each event is assigned a certain score and weighting coefficient, followed by aggregation of data to obtain an integral indicator at the system-organ and organism levels.
Conclusions. The algorithms proposed by the authors of the article for a systematic analysis of adverse events associated with the use of trastuzumab allow us to predict the safety of prescribed pharmacotherapy and, in the future, move to a risk-based approach when using this drug at the post-registration stage.
About the Authors
A. B. VervedaRussian Federation
Aleksey B. Verveda — PhD, Cand. Sci. (Med.), Leading Researcher; Senior Researcher
Saint-Petersburg
V. B. Vasilyuk
Russian Federation
Vasiliy B. Vasilyuk — Dr. Sci. (Med.), professor of the Department of Toxicology, Extreme and Diving Medicine North-Western State Medical University named after I. I. Mechnikov; Manager
Saint-Petersburg
G. I. Syraeva
Russian Federation
Gulnara I. Syraeva — PhD, Cand. Sci. (Med.), Assistant in the Department of Clinical Pharmacology and Evidence-Based Medicine; Deputy CEO
Saint-Petersburg
M. V. Faraponova
Russian Federation
Maria V. Faraponova — Deputy Manager for Scientific Work
Saint-Petersburg
A. V. Popov
Russian Federation
Andrey V. Popov — PhD, Cand. Sci. (Med.), Senior Lecturer, Department of Military Field Therapy
Saint-Petersburg
References
1. Verveda AB, Vasilyuk VB, Syraeva GI, Faraponova MV. Optimisation of approaches to adverse event analysis in bioequivalence clinical trials. Safety and Risk of Pharmacotherapy. 2024;12(1):24–34. (In Russ.)]. doi: 10.30895/2312-7821-2023-374.
2. Kagan ES. Construction of Comprehensive Fuzzy Evaluations of University Activity Effectiveness and Lecturer Activity Public Formalization. Izvestiya of Altai State University. 2015;1(85):152-7. (In Russ.)]. doi: 10.14258/izvasu(2015)1.1-27.
3. Georgitsa IV, Kuznetsova AV. Knowledge representation for fuzzy logic recruitment system. Sovremennye problemy nauki i obrazovaniya. 2015;1(1):125. (In Russ.)].
4. Zadeh LA. The role of soft computing and fuzzy logic in understanding, designing and developing information/intelligent systems. Novosti iskusstvennogo intellekta. 2001;2-3:7-11. (In Russ.)].
5. Poleshchuk OM. Building integral models within the framework of fuzzy expert information. Forestry Bulletin. 2003;5:155-9. (In Russ.)].
6. Adler YuP, Markova EV, Granovsky SE. Experiment planning in the search for optimal conditions Moscow: Nayka, 197 6. (In Russ.)].
7. Saati T, Tomas L. Decision-making : The method of hierarchy analysis. T. Saati; Translated from the English by RG Vachnadze. Moscow: Radio i svyaz', 1993. (In Russ.)]. ISBN 5-256-00443-3.
8. Klyushnikova EV, Shitova EM. Methodological approaches to calculation of integral index, ranking methods. Electronic Journal “InnoCentre”. 2016;1(10):4-18. (In Russ.)].
9. Makarova IL. Analysis of methods for determining weight coefficients in the integral indicator of public health. Simvol nauki. 2015;7:87-95. (In Russ.)].
Review
For citations:
Verveda A.B., Vasilyuk V.B., Syraeva G.I., Faraponova M.V., Popov A.V. Implementation of quantitative integral analysis in assessing events associated with safety issues during clinical trials: focusing on trastuzumab. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2024;(4):21-34. (In Russ.) https://doi.org/10.37489/2588-0519-2024-4-21-34. EDN: ZEWDXG